More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

The current pain caused by the high cost of the GLP-1 agonist anti-obesity drugs will pass. Prachi Patkee and other analysts ...

It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

Medically reviewed by Danielle Weiss, MD After losing extra pounds on Ozempic (semaglutide), some are finding themselves ...

New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat ...

Stopping semaglutide, marketed as Wegovy and Ozempic, which helps people lose weight , can have severe health impacts, a new ...

Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.